Medicover AB (publ)

MCOV-B · ST · Healthcare / Medical Care Facilities

261.00SEK-2.00 (-0.76%)

Price History

Full chart

Market Stats

Previous Close263.00

Open263.50

Day Range260.00 – 264.50

52-Week Range177.55 – 265.00

Volume99.35K

Market Cap38.60B

P/E (TTM)40.00

Forward P/E64.94

EPS6.35

Dividend Yield0.86%

Beta1.50

50-Day Avg240.91

200-Day Avg216.95

About

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMr. John Paul Stubbington
Employees49.00K
HeadquartersRiddargatan 12A, Stockholm, Sweden, 102 46, Sweden
Websitehttps://www.medicover.com

Leadership

Mr. John Paul StubbingtonChief Executive Officer · b. 1968
Mr. Fredrik RagmarkExecutive Officer · b. 1963
Mr. Anand PatelChief Financial Officer · b. 1974
Hanna BjellquistHead of Investor Relations
Ms. Jenny BrandtGeneral Legal Counsel · b. 1974
Dr. Andrew Vallance-Owen FRCS Ed, MBAChief Marketing Officer · b. 1951
Ms. Kamila SkorupinskiChief People Officer · b. 1973
Mr. Staffan TernstromChief Operating Officer for Diagnostic Services · b. 1965
Mr. Lukasz KrauseChief Digital Information Officer

Financials

Income Statement

Currency: EUR	2005-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	59.24M	365.30M	415.60M	497.30M	580.20M	671.60M	844.40M	997.80M	1.38B	1.51B	1.75B	2.09B	2.38B
Growth (%)	-	+516.69%	+13.77%	+19.66%	+16.67%	+15.75%	+25.73%	+18.17%	+38.04%	+9.64%	+15.64%	+19.78%	+13.69%
Cost of Revenue	36.41M	277.60M	314.90M	377.30M	438.20M	510.90M	637.60M	734.30M	982.40M	1.17B	1.39B	1.64B	1.83B
Gross Profit	22.83M	87.70M	100.70M	120.00M	142.00M	160.70M	206.80M	263.50M	395.00M	335.60M	359.40M	448.30M	550.70M
Gross Margin	38.54%	24.01%	24.23%	24.13%	24.47%	23.93%	24.49%	26.41%	28.68%	22.22%	20.58%	21.43%	23.16%
Operating Expense	20.82M	70.90M	79.20M	102.40M	113.20M	131.30M	160.30M	202.20M	235.60M	280.10M	298.00M	378.00M	395.00M
Operating Income	2.01M	16.80M	21.50M	17.60M	28.80M	29.40M	46.50M	61.30M	159.40M	55.50M	61.40M	70.30M	155.70M
Operating Margin	3.39%	4.60%	5.17%	3.54%	4.96%	4.38%	5.51%	6.14%	11.57%	3.68%	3.52%	3.36%	6.55%
EBITDA	-	33.40M	38.20M	40.20M	52.80M	61.80M	121.20M	151.60M	274.90M	215.90M	257.40M	171.20M	377.70M
EBITDA Margin	-	9.14%	9.19%	8.08%	9.10%	9.20%	14.35%	15.19%	19.96%	14.30%	14.74%	8.18%	15.88%
Net Income	1.40M	4.30M	7.50M	4.30M	18.70M	24.60M	22.50M	25.80M	101.80M	11.80M	17.60M	16.70M	77.50M
Net Income Margin	2.37%	1.18%	1.80%	0.86%	3.22%	3.66%	2.66%	2.59%	7.39%	0.78%	1.01%	0.80%	3.26%
R&D	-	-	-	-	-	-	1.50M	2.30M	2.70M	4.30M	5.60M	7.00M	-
R&D as % of Total Revenue	-	-	-	-	-	-	0.18%	0.23%	0.20%	0.28%	0.32%	0.33%	-
Interest Expense	0	2.80M	2.90M	4.60M	4.90M	4.00M	13.70M	18.10M	20.10M	34.50M	51.40M	58.80M	64.00M
Interest Expense % of Total Revenue	0.00%	0.77%	0.70%	0.92%	0.84%	0.60%	1.62%	1.81%	1.46%	2.28%	2.94%	2.81%	2.69%

Balance Sheet

Currency: EUR	2005-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	40.61M	269.60M	312.80M	419.50M	503.80M	611.20M	1.02B	1.11B	1.68B	1.83B	1.94B	2.14B	2.42B
Total Liabilities	17.06M	179.10M	219.60M	320.70M	199.80M	287.30M	659.80M	627.40M	1.12B	1.32B	1.41B	1.65B	1.88B
Total Equity	23.55M	88.60M	89.20M	92.70M	300.30M	319.40M	317.40M	448.00M	517.60M	474.70M	496.50M	464.80M	532.80M
Cash	9.25M	11.80M	17.20M	18.40M	45.40M	38.40M	34.80M	46.70M	81.90M	40.40M	50.80M	69.80M	82.30M
Total Debt	-	102.30M	129.30M	210.70M	57.20M	228.00M	451.50M	367.40M	764.60M	940.00M	1.00B	1.24B	1.44B
Net Debt	-	90.50M	112.10M	192.30M	11.80M	93.40M	416.70M	320.70M	682.70M	899.60M	952.90M	1.17B	1.36B

Cash Flow

Currency: EUR	2005-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	4.91M	21.70M	28.70M	25.90M	50.30M	44.40M	87.30M	156.00M	216.70M	170.20M	205.00M	261.90M	343.70M
Investing Cash Flow	-8.50M	-24.70M	-45.60M	-66.10M	-53.50M	-116.10M	-141.80M	-126.30M	-333.60M	-184.80M	-119.80M	-134.70M	-322.10M
Financing Cash Flow	9.52M	4.10M	22.60M	41.50M	31.30M	64.60M	48.80M	-14.10M	164.10M	-24.30M	-73.70M	-108.00M	-5.80M
Capital Expenditure	4.85M	23.60M	30.80M	54.30M	29.40M	41.00M	63.20M	72.50M	102.20M	140.60M	110.50M	122.30M	158.10M
Free Cash Flow	-	-1.90M	-2.10M	-28.40M	20.90M	3.40M	24.10M	83.50M	114.50M	29.60M	94.50M	139.60M	185.60M
Dividends Paid	-	-	-	-	-	10.40M	10.40M	10.40M	10.40M	17.80M	17.90M	18.00M	22.50M
FCF to OCF	-	-8.76%	-7.32%	-109.65%	41.55%	7.66%	27.61%	53.53%	52.84%	17.39%	46.10%	53.30%	54.00%
Dividend Paid to FCF	-	-	-	-	-	305.88%	43.15%	12.46%	9.08%	60.14%	18.94%	12.89%	12.12%

Earnings

Report Date	Jul 28, 2017	Oct 27, 2017	Feb 9, 2018	Apr 26, 2018	Jul 27, 2018	Oct 26, 2018	Feb 15, 2019	May 3, 2019	Jul 26, 2019	Nov 6, 2019	Feb 14, 2020	Apr 30, 2020	Jul 24, 2020	Nov 6, 2020	Feb 12, 2021	Apr 29, 2021	Jul 23, 2021	Nov 3, 2021	Feb 11, 2022	Apr 27, 2022	Jul 22, 2022	Nov 3, 2022	Feb 17, 2023	Apr 27, 2023	Jul 26, 2023	Nov 3, 2023	Feb 9, 2024	Apr 26, 2024	Jul 25, 2024	Oct 30, 2024	Feb 12, 2025	Apr 29, 2025	Jul 24, 2025	Nov 5, 2025	Feb 10, 2026	Apr 29, 2026	Jul 21, 2026	Nov 4, 2026
EPS Estimate	0.03	0.05	0.04	0.04	0.04	0.05	0.05	0.04	0.04	0.04	0.05	0.05	-0.06	0.05	-	0.20	0.27	0.20	-	0.13	0.02	0.01	1.75	1.75	-	-	0.03	0.03	0.06	0.07	0.03	0.06	0.11	0.09	0.09	0.12	0.16	0.19
EPS Actual	0.02	0.03	0.07	0.07	0.05	0.04	0.03	0.05	0.04	0.04	0.06	-0.06	-0.05	0.12	1.26	0.18	0.22	0.14	0.21	0.08	0.02	1.44	1.44	1.44	0.42	-0.08	0.09	0.06	0.07	-0.01	0.06	0.15	0.16	0.15	0.15	0.16	0.16	-
Surprise	-33.33%	-40.00%	75.00%	75.00%	25.00%	-20.00%	-40.00%	25.00%	0.00%	0.00%	20.00%	-228.00%	16.67%	140.00%	-	-10.00%	-18.52%	-30.00%	-	-38.46%	0.00%	14300.00%	-17.71%	-17.71%	-	-	200.00%	100.00%	16.67%	-114.29%	81.25%	150.00%	45.45%	66.67%	66.67%	33.33%	0.00%	-
Timing	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market

Key Statistics & Ratios

Market Cap38.60B

Enterprise Value54.78B

Trailing P/E40.00

Forward P/E64.94

Price / Sales15.64

Price / Book6.51

EPS6.35

Book Value3.53

Revenue (TTM)2.47B

Gross Profit (TTM)576.80M

EBITDA279.30M

Profit Margin3.44%

Operating Margin8.00%

Return on Equity15.49%

Return on Assets4.66%

Shares Outstanding75.42M

Shares Float53.13M

Beta1.50

Dividend Yield0.86%

Dividend Rate2.18

Payout Ratio3.64%

Dividends

20261×

2.26Apr 30, 2026

20251×

1.69Apr 30, 2025

20241×

1.35Apr 29, 2024

20231×

1.35Apr 28, 2023

20221×

1.35Apr 28, 2022

20211×

0.79Apr 30, 2021